Gapping down
In reaction to earnings/guidance:
- CSPR -12.5%, JD -2.2%
Other news:
- RAPT -21.2% (reports initial clinical data from its ongoing Phase 1/2 trial for FLX475 in multiple cancer indications)
- ZM -5.9% (work from home play out of favor in early trade)
- QDEL -4.8% (Quidel CEO on CNBC: Tests will continue to be useful, even if we get a vaccine)
- LOGI -3.5% (work from home play out of favor in early trade)
- VXX -2.8% (trading lower with US futres off to a strong start)
- REZI -2.5% (files mixed securities shelf offering)
- KOD -2.4% (completes enrollment of DAZZLE Phase 2b/3 pivotal study of KSI-301)
- GH -1.8% (proposes $1 bln principal amount of convertible senior notes due 2027)